Paclitaxel/Cyclophosphamide and High-Dose Melphalan/Etoposide Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IIIB Inflammatory Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00019162
Information provided by National Cancer Institute (NCI)
First Received: July 11, 2001
Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
